ENRIQUE DELEON: Open Payments
NPI 1457449308 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,633 in 134 payments from 21 companies in 2025. Trend: 2023 $2,865 · 2024 $2,533 · 2025 $2,633
Food & beverage: $2,633
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $662 |
| Novo Nordisk Inc | 18 | $411 |
| AstraZeneca Pharmaceuticals LP | 13 | $263 |
| Lilly USA, LLC | 20 | $240 |
| GlaxoSmithKline, LLC. | 8 | $173 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $156 |
| PFIZER INC. | 6 | $121 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $106 |
| Phathom Pharmaceuticals, Inc. | 4 | $59 |
| Amgen Inc. | 3 | $55 |
Products named: VRAYLAR, MOUNJARO, Ozempic, Wegovy, Kerendia, JARDIANCE, QULIPTA, UBRELVY.
Industry payments across CA — which companies pay providers there.
